Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

The year's top conference coverage item shares the effects of "Ozempic Bod" and "Ozempic Face," as presented at the annual ...

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

FDA officials have set a review date of June 30, 2025, to review avutometinib in combination with defactinib to treat ...

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...

This year’s top dermatology posts on Managed Healthcare Executive include stories about Gen Z sunscreen trends and increasing ...